Within 48 hours of admission in patients with COPD and acute respiratory symptoms, they applied a predefined pulmonary embolism diagnostic algorithm based on Geneva score,. ... In practice, clinicians should consider the probability of an underlying
included by CMS to avoid gaming of the system by miscoding of COPD patients). ... After implementation of the program, 30-day readmissions of COPD patients went down.
long-acting beta-agonist and inhaled corticosteroid (LABA-ICS) combination therapy after hospital discharge in older adults with COPD. ... well as standardized practices to prevent medication errors at hospital discharge in the COPD population,” the
Up to 80% of exacerbations of COPD are due to infection,” said Dr. ... It's particularly interesting that they come back in with COPD,” she said.
A systematic review of 68 randomized controlled trials found scant evidence supporting other pharmacologic interventions to treat adults with mild to severe exacerbation of chronic obstructive pulmonary disease (COPD). ... Antibiotics and systemic
A 63-year-old man is admitted to the ICU for an exacerbation of COPD. ... The anti-inflammatory effects of simvastatin were previously believed to reduce exacerbations in COPD.
Patients with eosinophilic exacerbations are clinically indistinguishable from other patients with severe COPD exacerbations, but they may respond more rapidly to corticosteroid treatment. ... A higher eosinophil count is associated with shorter length
Chronic obstructive pulmonary disease (COPD) is one of the most frequent reasons for inpatient admission. ... method), and it is used primarily to exclude alternative diagnoses or to identify complications of COPD.
Researchers searched MEDLINE and EMBASE from 1974 to October 2015 and included 7 studies of patients with unexplained COPD exacerbations in their review. ... COPD exacerbations, can increase venous thromboembolism risk; and pulmonary embolism could
They were also more likely to be prescribed calcium-channel blockers and diuretics and took more COPD medications at baseline. ... The results suggest that MI patients with COPD may benefit from beta-blockers, the study authors concluded.